- Home
- TRX vs SRZN Comparison
TRX vs SRZN Comparison
Compare TRX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRX
- SRZN
- Stock Information
- Founded
- TRX 1990
- SRZN 2015
- Country
- TRX Canada
- SRZN United States
- Employees
- TRX N/A
- SRZN N/A
- Industry
- TRX
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- TRX
- SRZN Health Care
- Exchange
- TRX Nasdaq
- SRZN Nasdaq
- Market Cap
- TRX 90.0M
- SRZN 82.8M
- IPO Year
- TRX N/A
- SRZN N/A
- Fundamental
- Price
- TRX $0.30
- SRZN $7.10
- Analyst Decision
- TRX Strong Buy
- SRZN Strong Buy
- Analyst Count
- TRX 1
- SRZN 2
- Target Price
- TRX $1.50
- SRZN $38.50
- AVG Volume (30 Days)
- TRX 432.6K
- SRZN 11.0K
- Earning Date
- TRX 04-14-2025
- SRZN 05-09-2025
- Dividend Yield
- TRX N/A
- SRZN N/A
- EPS Growth
- TRX N/A
- SRZN N/A
- EPS
- TRX N/A
- SRZN N/A
- Revenue
- TRX $45,405,000.00
- SRZN $11,638,000.00
- Revenue This Year
- TRX $51.45
- SRZN N/A
- Revenue Next Year
- TRX $26.19
- SRZN N/A
- P/E Ratio
- TRX N/A
- SRZN N/A
- Revenue Growth
- TRX 26.50
- SRZN N/A
- 52 Week Low
- TRX $0.27
- SRZN $6.00
- 52 Week High
- TRX $0.49
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- TRX 45.42
- SRZN 31.40
- Support Level
- TRX $0.30
- SRZN $9.96
- Resistance Level
- TRX $0.33
- SRZN $11.56
- Average True Range (ATR)
- TRX 0.01
- SRZN 0.96
- MACD
- TRX -0.00
- SRZN -0.29
- Stochastic Oscillator
- TRX 12.33
- SRZN 21.20
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).